<DOC>
	<DOCNO>NCT02015767</DOCNO>
	<brief_summary>A patient registry capture real life data demonstrate performance roflumilast ( Daxas速 ) standard clinical practice .</brief_summary>
	<brief_title>Patient Registry Roflumilast In Real Life</brief_title>
	<detailed_description>The drug test observational study design call roflumilast , therapeutic intervention . Roflumilast approve market globally maintenance treatment severe Chronic Obstructive Pulmonary Disease ( COPD ) associate chronic bronchitis adult patient history frequent exacerbation add bronchodilator treatment . This study capture real life data demonstrate performance roflumilast standard clinical practice . The study enroll approximately 1350 ( EU ) +600 ( North Asia ) patient . This multi-centre trial conduct least 4 EU 2 North Asian country . The overall time participate study 12 month . No visit , diagnostic procedure monitor take place , would happen patient include study . Participants follow accord usual practice data record approximately 6 month 12 month roflumilast treatment .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Signed informed consent data collection Roflumilast ( Daxas速 ) treatment initiate Roflumilast ( Daxas速 ) na誰ve patient time registry There exclusion criterion per se . However expect patient treat accord locally approve marketing authorisation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Drug therapy</keyword>
</DOC>